"Every patient who faces the prospect of an organ transplant needs a miracle. That’s because organ transplantation is typically only for patients who have few—if any—options. Fortunately, patients and their families who choose Miami Transplant Institute can take comfort knowing they have chosen the nation’s leading transplant center. Jackson Health System and UHealth – the University of Miami Health System have built the Miami Transplant Institute into an internationally revered team of doctors, nurses, and other healthcare professionals. They have come to our community from Europe, South America, and Asia to form an unmatched team of experts committed to serving individual patients while advancing the global science of transplant."

During the past decade, Miami Transplant Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Miami Transplant Institute" #1 collaborator was "Ann & Robert H Lurie Children's Hospital of Chicago" with 1 trials as a collaborator, "Baylor College of Medicine" with 1 trials as a collaborator, "Children's Hospital Los Angeles" with 1 trials as a collaborator, "Children's Hospital of Michigan" with 1 trials as a collaborator and "Children's Hospital of Philadelphia" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Miami Transplant Institute" are "Adult Primary Kidney Transplantation" (1 trials), "Diabetes Mellitus, Type 1" (1 trials), "Hiv" (1 trials), "Liver Disease Chronic" (1 trials) and "Living-Donor Kidney Transplant" (1 trials). Many other conditions were trialed in "Miami Transplant Institute" in a lesser frequency.

Most popular intervention types in "Miami Transplant Institute" are "Drug" (4 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Campath-1H" (2 trials), "Daclizumab" (2 trials), "Thymoglobulin" (2 trials), "HIV D+/R+" (1 trials) and "Inspiratory Muscle Training" (1 trials). Other intervention names were less common.

The vast majority of trials in "Miami Transplant Institute" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Miami Transplant Institute". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Miami Transplant Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Miami Transplant Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".